Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val Gebski

Showing results (131-140 of 248) with videos related to

Pageof 25
Sort By:
The Lancet. Oncology|July 9, 2022
Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 studyRobert P Carroll, Michael Boyer, Val Gebski, et al.
International Journal of Cancer|September 16, 2011
The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancerJames Nicklin, Monika Janda, Val Gebski, et al.
Asia-Pacific Journal of Clinical Oncology|June 28, 2021
Combination chemotherapy with NAB<sup>®</sup> -paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP-CAPABIL Pilot Study)Rachel Woodford, Daniel Brungs, Carly Leighton, et al.
Frontiers in Psychology|October 16, 2023
Neuropsychiatric correlates of olfactory identification and traumatic brain injury in a sample of impulsive violent offendersVasudeva Murthy Challakere Ramaswamy, Tony Butler, Bianca Ton, et al.
JMIR Research Protocols|March 30, 2017
Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal CancerPradeep S Virdee, Joanna Moschandreas, Val Gebski, et al.
The Medical Journal of Australia|June 20, 2012
Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosisSarah J Lord, M Luke Marinovich, Jillian A Patterson, et al.
Journal of Cancer Research and Clinical Oncology|October 31, 2022
Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancerKatrin M Sjoquist, Andrew Martin, Nick Pavlakis, et al.
JAMA Oncology|December 23, 2017
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysisChee Khoon Lee, Johnathan Man, Sally Lord, et al.
BMC Cancer|July 19, 2015
Audiovisual biofeedback breathing guidance for lung cancer patients receiving radiotherapy: a multi-institutional phase II randomised clinical trialSean Pollock, Ricky O'Brien, Kuldeep Makhija, et al.
Infection Control and Hospital Epidemiology|December 8, 2010
Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization or infection associated with a multifaceted infection control interventionKatherine Ellingson, Robert R Muder, Rajiv Jain, et al.
Pageof 25

Showing results (131-140 of 248) with videos related to

Sort By:
Pageof 25
The Lancet. Oncology|July 9, 2022
Immune checkpoint inhibitors in kidney transplant recipients: a multicentre, single-arm, phase 1 studyRobert P Carroll, Michael Boyer, Val Gebski, et al.
International Journal of Cancer|September 16, 2011
The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancerJames Nicklin, Monika Janda, Val Gebski, et al.
Asia-Pacific Journal of Clinical Oncology|June 28, 2021
Combination chemotherapy with NAB<sup>®</sup> -paclitaxel and capecitabine for patients with advanced biliary tract cancer (NAP-CAPABIL Pilot Study)Rachel Woodford, Daniel Brungs, Carly Leighton, et al.
Frontiers in Psychology|October 16, 2023
Neuropsychiatric correlates of olfactory identification and traumatic brain injury in a sample of impulsive violent offendersVasudeva Murthy Challakere Ramaswamy, Tony Butler, Bianca Ton, et al.
JMIR Research Protocols|March 30, 2017
Protocol for Combined Analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global Randomized Phase III Trials of Chemotherapy +/- Selective Internal Radiation Therapy as First-Line Treatment for Patients With Metastatic Colorectal CancerPradeep S Virdee, Joanna Moschandreas, Val Gebski, et al.
The Medical Journal of Australia|June 20, 2012
Incidence of metastatic breast cancer in an Australian population-based cohort of women with non-metastatic breast cancer at diagnosisSarah J Lord, M Luke Marinovich, Jillian A Patterson, et al.
Journal of Cancer Research and Clinical Oncology|October 31, 2022
Value of central review of RECIST v1.1 outcomes in the AGITG INTEGRATE randomised phase 2 international trial for advanced oesophago-gastric cancerKatrin M Sjoquist, Andrew Martin, Nick Pavlakis, et al.
JAMA Oncology|December 23, 2017
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysisChee Khoon Lee, Johnathan Man, Sally Lord, et al.
BMC Cancer|July 19, 2015
Audiovisual biofeedback breathing guidance for lung cancer patients receiving radiotherapy: a multi-institutional phase II randomised clinical trialSean Pollock, Ricky O'Brien, Kuldeep Makhija, et al.
Infection Control and Hospital Epidemiology|December 8, 2010
Sustained reduction in the clinical incidence of methicillin-resistant Staphylococcus aureus colonization or infection associated with a multifaceted infection control interventionKatherine Ellingson, Robert R Muder, Rajiv Jain, et al.
Pageof 25